Protalix BioTherapeutics, Inc. financial data

Symbol
PLX on NYSE
Location
2 University Plaza, Suite 100, Hackensack, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 263 % +77.6%
Quick Ratio 86.6 % +99.4%
Debt-to-equity 61.1 % -62.6%
Return On Equity 11.3 %
Return On Assets 7 %
Operating Margin 10.3 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 80.4M shares +9.22%
Common Stock, Shares, Outstanding 75.9M shares +3.97%
Entity Public Float 82M USD -41.1%
Common Stock, Value, Issued 76K USD +4.11%
Weighted Average Number of Shares Outstanding, Basic 79.3M shares +7.79%
Weighted Average Number of Shares Outstanding, Diluted 80.8M shares -0.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 61.8M USD +35.4%
Cost of Revenue 26.3M USD -10.3%
Research and Development Expense 18.1M USD +51.1%
Operating Income (Loss) 6.37M USD -46.6%
Nonoperating Income (Expense) 117K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6.48M USD -41.7%
Income Tax Expense (Benefit) 1.09M USD +5956%
Net Income (Loss) Attributable to Parent 5.39M USD -27.2%
Earnings Per Share, Basic 0 USD/shares -25%
Earnings Per Share, Diluted 0 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.6M USD -50.2%
Accounts Receivable, after Allowance for Credit Loss, Current 14.4M USD +557%
Inventory, Net 21.3M USD +23.6%
Other Assets, Current 1.45M USD +38.3%
Assets, Current 66.5M USD +39%
Deferred Income Tax Assets, Net 2.68M USD -6.2%
Property, Plant and Equipment, Net 4.72M USD +1.64%
Operating Lease, Right-of-Use Asset 7.81M USD +38.4%
Assets 82.3M USD +33.6%
Accounts Payable, Current 19.6M USD +4.47%
Employee-related Liabilities, Current 745K USD -40.4%
Accrued Liabilities, Current 8.13M USD -2.59%
Contract with Customer, Liability, Current 12.7M USD
Liabilities, Current 21.9M USD -9.39%
Operating Lease, Liability, Noncurrent 6.78M USD +62.4%
Liabilities 29.4M USD +0.79%
Retained Earnings (Accumulated Deficit) -378M USD +0.83%
Stockholders' Equity Attributable to Parent 52.9M USD +63.1%
Liabilities and Equity 82.3M USD +33.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.06M USD -221%
Net Cash Provided by (Used in) Financing Activities 5.08M USD
Net Cash Provided by (Used in) Investing Activities -312K USD +48.5%
Common Stock, Shares Authorized 185M shares 0%
Common Stock, Shares, Issued 75.9M shares +3.97%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -302K USD -108%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13.6M USD -50.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 766K USD -28.9%
Deferred Tax Assets, Valuation Allowance 50.7M USD -1.85%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 8.18M USD
Depreciation 346K USD +7.45%
Payments to Acquire Property, Plant, and Equipment 306K USD -48.8%
Lessee, Operating Lease, Liability, to be Paid 26.9M USD
Property, Plant and Equipment, Gross 40.3M USD +1.69%
Operating Lease, Liability, Current 1.4M USD -7.36%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.14M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.4M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure +7.81%
Deferred Income Tax Expense (Benefit) 177K USD -86.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 18.7M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.07M USD
Deferred Tax Assets, Operating Loss Carryforwards 50M USD -2.83%
Current Income Tax Expense (Benefit) -175K USD -207%
Preferred Stock, Shares Authorized 100M shares
Unrecognized Tax Benefits 805K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.04M USD
Operating Lease, Payments 457K USD +10.7%
Deferred Tax Assets, Net of Valuation Allowance 2.86M USD -7.63%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares